Hematopoietic SH2 Domain Containing (HSH2D) (Middle Region) Peptid
HSH2D
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle HSH2D Produkte
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- TQPCRQKDPA NVDYEDLFLY SNAVAEEAAC PVSAPEEASP KPVLCHQSKE
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- HSH2D Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
- Hintergrund
-
T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor and a costimulatory signal provided primarily by CD28 in naive T cells. HSH2 is a target of both of these signaling pathways.
Alias Symbols: ALX, HSH2
Protein Size: 295 - Gen-ID
- 84941
- NCBI Accession
- NM_001291274, NP_001278203
-
Sie sind hier:
